Form 4 for ENVB Enveric Biosciences, Inc.

Accepted 2023-01-25 00:00:00 ET · period of report 2021-10-13 · accession 0001493152-23-002453 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-01-25	2021-10-13	ENVB	Tucker Joseph Edward	CEO, Dir	A - Grant	$0.00	+16.4K	15.2K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-10-13	A	A	15,000	$0.00	30,196	D	—	—	(F3) 50% of the RSUs shall vest over 4 years in equal annual installments, with the first tranche to vest on September 16, 2022. 50% of the RSUs shall vest in 3 approximately equal tranches on each of December 31, 2022, 2023 and 2024, if the Company's average VWAP (calculated as the average over the fourth calendar quarter of each of 2022, 2023 and 2024, as applicable, of the daily volume weighted average price of a share of common stock), exceeds $119.00, $130.50 and 143.50, respectively. (F2) Includes 13,822 shares previously held through the Tucker 2020 Family Trust, which were distributed to the reporting person and are now owned directly.
2	Common	Common Stock	2021-10-13	A	A	1,374	$0.00	15,196	D	—	—	(F1) The reporting person received the RSUs as a one-time signing bonus upon the commencement of the reporting person's employment with the Company. 50% of the RSUs shall vest over 2 years in equal annual installments, with the first tranche to vest on September 16, 2022. 50% of the RSUs shall vest over 2 years in equal annual installments, if the Company's average VWAP exceeds 110% and 120% of $158.925, respectively. (F2) Includes 13,822 shares previously held through the Tucker 2020 Family Trust, which were distributed to the reporting person and are now owned directly.